Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing crisaborole

A technology of cressaboron and pinacol biboronate is applied in the field of preparation of cresaborate, which can solve the problems of difficult purification of products, low total yield, complicated steps and the like

Inactive Publication Date: 2019-03-26
成都安满生物医药科技有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] The problem to be solved by the present invention is to provide a kind of Cresabron in order to overcome the defects of cumbersome steps, harsh reaction conditions, low total yield, difficult purification of the product and unsuitability for industrial production in the existing preparation method of cresabron. The preparation method of boron

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing crisaborole
  • Method for preparing crisaborole
  • Method for preparing crisaborole

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] For the preparation of Intermediate III, the reaction formula is as follows:

[0057]

[0058] Add 2-bromo-5-hydroxybenzyl alcohol II (374g, 1.84mol), N,N-dimethylformamide (2.2L), potassium carbonate (509g, 2mol) and p-fluorobenzonitrile ( 223.1g, 1.84mol), after the addition, the reaction system was heated to 80-90°C for reaction, TLC monitored until the reaction was complete, and the system was slowly added to water (4.4L) for quenching.

[0059] Filtration and drying to obtain an off-white solid, ie Intermediate III, with an HPLC purity of 96.5% and a yield of 95.7%; 1 HNMR(300MHz, CDCl 3 )δ(ppm): 4.75(s, 2H), 6.88(dd, J=8.5, 2.9Hz, 1H), 7.02(d, J=8.8Hz, 1H), 7.26(d, J=2.6Hz, 1H) , 7.56 (d, J=8.5 Hz, 1H), 7.62 (d, J=8.8 Hz, 2H).

Embodiment 2

[0061] For the preparation of Intermediate III, the reaction formula is as follows:

[0062]

[0063] Add 2-bromo-5-hydroxybenzyl alcohol II (20.3g, 0.1mol), N,N-dimethylformamide (50mL), potassium carbonate (27.6g, 0.2mol) and p-fluorobenzene to a three-necked flask in sequence Nitrile (14.5g, 0.12mol), after the addition, the reaction system was heated to 80-90°C for reaction, TLC monitored until the reaction was complete, and the system was slowly added to water (250mL) for quenching.

[0064] After filtration and drying, an off-white solid, ie Intermediate III, was obtained with an HPLC purity of 93.5% and a yield of 96.2%.

Embodiment 3

[0066] For the preparation of Intermediate IV, the reaction formula is as follows:

[0067]

[0068] Intermediate III (30.4g, 0.1mol), dichloromethane (300ml), 2,3-dihydropyran (16.8g, 0.2mol) and p-toluenesulfonic acid monohydrate (1.9g, 0.01 mol), stirring overnight at room temperature.

[0069] Add 100ml of 1% ammonia water to the system, stir to separate the liquids, dry the organic phase with anhydrous sodium sulfate, filter, and concentrate to obtain a yellow oil. Add petroleum ether to crystallize to obtain an off-white solid, ie Intermediate IV, with a purity of 98.7% by HPLC , The yield is 88%; 1 HNMR(300MHz, CDCl 3 )δ(ppm) 1.64~1.86(m, 6H), 3.55(m, 1H), 3.88(m, 1H), 4.53(d, J=10.5Hz, 1H), 4.77(d, J=10.2, 2.7Hz , 2H), 6.84 (dd, J = 8.7, 4.2 Hz, 1H), 7.01 (dd, J = 6.6, 3.6 Hz, 2H), 7.27 (d, J = 2.4 Hz, 1H), 7.54 (d, J = 6.3 Hz, 1H), 7.60 (dd, J=6.6, 3.6 Hz, 2H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing crisaborole shown as a formula I. The preparation method disclosed by the invention comprises the following steps: carrying out the following reaction between a compound IV and bis(pinacolato)diboron in a solvent in the presence of alkali and a catalyst, thereby obtaining the compound V. The preparation method disclosed by the invention has the characteristics of being readily available in raw materials, simple in steps, mild in reaction conditions, controllable in quality, environmental-friendly, low in cost and the like. The industrial production of the bulk drug is facilitated, and development of the economic technology is promoted. The structural formula is as shown in the specification.

Description

Technical field [0001] The present invention relates to a preparation method of crenzaboron. Background technique [0002] Crisaborole was developed by Anacor Pharmaceuticals. It is a phosphodiesterase 4 (PDE4) inhibitor. This inhibition leads to increased levels of intracellular cyclic adenosine monophosphate (CAMP). The topical treatment of mild to moderate allergic dermatitis in patients 2 years and older has broad prospects. On December 14, 2016, it was approved by the U.S. Food and Drug Administration (FDA) under the trade name Eucrisa. [0003] The chemical name of Creisaboron is 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborolan-5-yl)oxy]benzonitrile I, which The structural formula is: [0004] [0005] The preparation method of cresarboron has been reported. In Bioorganic&Medicinal Chemistry Letters 19(2009) 2129-2132, Tsutomu Akama et al. reported that 2-bromo-5-hydroxybenzaldehyde is used as the raw material, and the aromatic ring is protected. Nucleophilic substitution, depr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07F5/02C07D309/12C07C253/30C07C255/54
CPCC07C253/30C07D309/12C07F5/025C07C255/54
Inventor 曾亮资春鹏谭君成
Owner 成都安满生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com